Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowl...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Korol AR, Zborovska O, Kustryn T, Dorokhova O, Pasyechnikova N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/e688b2d24370457380265d79bd4cf4cb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e688b2d24370457380265d79bd4cf4cb
record_format	dspace
spelling	oai:doaj.org-article:e688b2d24370457380265d79bd4cf4cb2021-12-02T01:08:46ZIntravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]1177-5483https://doaj.org/article/e688b2d24370457380265d79bd4cf4cb2017-08-01T00:00:00Zhttps://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original articleKorol ARZborovska OKustryn TDorokhova OPasyechnikova NDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1567-1568 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
description	Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original article
format	article
author	Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N
author_facet	Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N
author_sort	Korol AR
title	Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_short	Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_full	Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_fullStr	Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_full_unstemmed	Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_sort	intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [corrigendum]
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/e688b2d24370457380265d79bd4cf4cb
work_keys_str_mv	AT korolar intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT zborovskao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT kustrynt intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT dorokhovao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT pasyechnikovan intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
_version_	1718403287996170240

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Ejemplares similares